Daniel Gallacher

761 total citations
26 papers, 473 citations indexed

About

Daniel Gallacher is a scholar working on Economics and Econometrics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Gallacher has authored 26 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Gallacher's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (4 papers) and Economic and Financial Impacts of Cancer (3 papers). Daniel Gallacher is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (4 papers) and Economic and Financial Impacts of Cancer (3 papers). Daniel Gallacher collaborates with scholars based in United Kingdom, United States and Canada. Daniel Gallacher's co-authors include Rachel Upthegrove, Steven Marwaha, Jayanta Chatterjee, Benjamin I. Perry, Nicholas M. Barnes, Tobias Rowland, Peter Kimani, A. Keane, Peter Auguste and Nigel Stallard and has published in prestigious journals such as Journal of Bone and Joint Surgery, The British Journal of Psychiatry and Optics Express.

In The Last Decade

Daniel Gallacher

24 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Gallacher United Kingdom 11 101 89 74 70 67 26 473
Yuntao Chen China 16 54 0.5× 6 0.1× 3 0.0× 38 0.5× 45 0.7× 45 829
Christopher N. Foley United Kingdom 13 46 0.5× 80 0.9× 5 0.1× 40 0.6× 3 0.0× 15 1.4k
Nick Shrine United Kingdom 14 40 0.4× 28 0.3× 49 0.7× 8 0.1× 3 0.0× 32 560
Alberto Ferrari Italy 15 22 0.2× 7 0.1× 6 0.1× 11 0.2× 13 0.2× 36 688
Michael Spain United States 14 84 0.8× 115 1.3× 14 0.2× 10 0.1× 1 0.0× 20 1.2k
Ai Hori Japan 14 18 0.2× 8 0.1× 18 0.2× 77 1.1× 5 0.1× 53 685
Kalpana J. Kallianpur United States 20 55 0.5× 71 0.8× 10 0.1× 18 0.3× 4 0.1× 58 975
T. Moreau France 18 112 1.1× 6 0.1× 8 0.1× 77 1.1× 2 0.0× 67 1.2k
L. Briatore Italy 15 19 0.2× 5 0.1× 16 0.2× 10 0.1× 33 0.5× 42 679
David Summers United Kingdom 15 54 0.5× 62 0.8× 14 0.2× 95 1.4× 56 899

Countries citing papers authored by Daniel Gallacher

Since Specialization
Citations

This map shows the geographic impact of Daniel Gallacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gallacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gallacher more than expected).

Fields of papers citing papers by Daniel Gallacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Gallacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gallacher. The network helps show where Daniel Gallacher may publish in the future.

Co-authorship network of co-authors of Daniel Gallacher

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Gallacher. A scholar is included among the top collaborators of Daniel Gallacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Gallacher. Daniel Gallacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geppert, Julia, Peter Auguste, Hesam Ghiasvand, et al.. (2025). Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation. Health Technology Assessment. 29(14). 1–234. 3 indexed citations
2.
Elfeky, Adel, Adam Boulton, Rachel Court, et al.. (2025). Innovative ventilation technologies used in the intensive care unit for adults and children: a scoping review. NIHR Open Research. 5. 1–1.
3.
Kunst, Natalia, et al.. (2025). Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria. PharmacoEconomics. 43(5). 499–508. 1 indexed citations
4.
Farhan-Alanie, Muhamed M, Daniel Gallacher, James M. Griffin, et al.. (2025). The Effects of Computer Navigation and Patient-Specific Instrumentation on Risk of Revision, PROMs, and Mortality Following Primary TKR. Journal of Bone and Joint Surgery. 107(8). 829–839.
5.
Gallacher, Daniel. (2024). SurvInt: a simple tool to obtain precise parametric survival extrapolations. BMC Medical Informatics and Decision Making. 24(1). 76–76. 2 indexed citations
6.
Geppert, Julia, Emma Helm, Daniel Todkill, et al.. (2024). Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies. Thorax. 79(11). 1040–1049. 15 indexed citations
7.
Farhan-Alanie, Muhamed M, Sam Jonas, Daniel Gallacher, Michael R. Whitehouse, & Tim Chesser. (2023). Fewer native and periprosthetic femoral fracture patients receive an orthogeriatric review and expedited surgery compared to hip fracture patients. Hip International. 34(2). 281–289. 2 indexed citations
8.
9.
Gallacher, Daniel, Peter Kimani, & Nigel Stallard. (2021). Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations. PharmacoEconomics. 40(1). 109–120. 1 indexed citations
10.
Mottram, Rebecca, Wendy Knerr, Daniel Gallacher, et al.. (2021). Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis. BMJ Open. 11(11). e046660–e046660. 53 indexed citations
11.
Gallacher, Daniel, Peter Kimani, & Nigel Stallard. (2021). Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study. Medical Decision Making. 41(4). 476–484. 7 indexed citations
12.
Bannon, Christopher, Daniel Gallacher, Petra Hanson, et al.. (2020). Systematic review and meta‐analysis of the metabolic effects of modified‐release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency. Clinical Endocrinology. 93(6). 637–651. 6 indexed citations
13.
Kearney, Rebecca, Rebecca McKeown, Daniel Gallacher, et al.. (2019). Ankle injury rehabilitation (AIR): a feasibility randomised controlled trial comparing functional bracing to plaster cast in the treatment of adult ankle fractures. Pilot and Feasibility Studies. 5(1). 55–55. 7 indexed citations
14.
Gallacher, Daniel, Peter Auguste, & Martin Connock. (2019). How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017. International Journal of Technology Assessment in Health Care. 35(2). 160–167. 16 indexed citations
15.
Smyth, Michael A., et al.. (2019). Derivation and internal validation of the screening to enhance prehospital identification of sepsis (SEPSIS) score in adults on arrival at the emergency department. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 27(1). 67–67. 10 indexed citations
16.
17.
Rowland, Tobias, Benjamin I. Perry, Rachel Upthegrove, et al.. (2018). Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. The British Journal of Psychiatry. 213(3). 514–525. 137 indexed citations
18.
Gallacher, Daniel, Xavier Armoiry, Peter Auguste, et al.. (2018). Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(1). 19–27. 9 indexed citations
19.
Yang, Jian, et al.. (2017). Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/− Mice Is Superior to Everolimus Alone. Neoplasia. 19(2). 112–120. 6 indexed citations
20.
Keane, A., et al.. (2016). An analytical model for a full wind turbine wake. Journal of Physics Conference Series. 753. 32039–32039. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuntao Chen Breakdown of academic impact, for papers by Christopher N. Foley Breakdown of academic impact, for papers by Nick Shrine Breakdown of academic impact, for papers by Alberto Ferrari Breakdown of academic impact, for papers by Michael Spain Breakdown of academic impact, for papers by Ai Hori Breakdown of academic impact, for papers by Kalpana J. Kallianpur Breakdown of academic impact, for papers by T. Moreau Breakdown of academic impact, for papers by L. Briatore Breakdown of academic impact, for papers by David Summers
Rankless by CCL
2026